CTX-M: changing the face of ESBLs in Europe
D. M. Livermore, N. Woodford(Public Health England), Gian María Rossolini(University of Siena), Izabela Kern-Zdanowicz(Institute of Biochemistry and Biophysics, Polish Academy of Sciences), Rafael Cantón(Instituto Ramón y Cajal de Investigación Sanitaria), Patrice Nordmann(University of Fribourg), Juan A. Ayala(Consejo Superior de Investigaciones Científicas), Marek Gniadkowski(Narodowy Instytut Leków), Laurent Poirel(University of Fribourg), Guillaume Arlet(Sorbonne Université), Teresa M. Coque(Instituto Cajal), Francesco Luzzaro(University of Insubria)
Cited by 923
Related Papers
Defining and combating antibiotic resistance from One Health and Global Health perspectives
|Nature Microbiology|2019|1.2k
The CTX-M β-lactamase pandemic
|Current Opinion in Microbiology|2006|1.1k
What is a resistance gene? Ranking risk in resistomes
|Nature Reviews Microbiology|2014|1k
CTX-M Enzymes: Origin and Diffusion
|Frontiers in Microbiology|2012|955
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe
|Eurosurveillance|2008|800